Executive Director, Global Program Lead - Next Generation (Immunology & Cardiovascular)

Role Summary

Executive Director, Global Program Lead - Next Generation (Immunology & Cardiovascular) leads strategic development and execution of asset programs across late-stage discovery to commercialization, overseeing multi-disciplinary teams to achieve near- and long-term portfolio objectives.

Responsibilities

• Uses understanding of disease biology and drug development to create a vision for each asset and design/execute development programs aligned with overall portfolio goals.
• Engages cross-company expertise and governance bodies to define and champion asset development strategies and plans.
• Continuously analyzes progress, applies critical thinking, and facilitates data-driven decision making.
• Delivers high-quality assets with potential for competitive profiles and favorable shareholder return.
• Ensures program outputs meet standards, budgets, timelines, and regulatory/compliance requirements while seeking continuous improvement.
• Aligns program strategy with functional capabilities and communicates risks and milestone progress to senior leaders.
• Provides input to portfolio-level strategy for internal and external opportunities.
• Participates in regulatory filings and develops strategies for orphan designation; engages with Health Authorities/Advisory Committees in trial design.
• Leads development of program strategy, clinical programs, commercialization plans, business cases, and designs trials with value proposition considerations like access, pricing, and reimbursement.
• Builds and maintains relationships with external stakeholders and incorporates insights to maximize impact.
• Manages clinical trial operations from startup to readout; analyzes data and translates findings into scientific communications and commercial strategy.
• Incorporates input from market, regulatory, and commercial considerations into trial design and labeling strategy.
• Forecasts investment scenarios, assesses risk, and informs decision-making; contributes to brand strategy and messaging in context of clinical development.
• Supports development of KOL plans and leverages input for evidence-based communications; advises on trade packaging and commercial product considerations.

Qualifications

• MD, PhD, DVM, PharmD, MBA or equivalent advanced degree with drug development experience.
• 10+ years of experience in drug development and leadership in academic or industry settings.
• Expertise in drug development with matrix leadership experience and regulatory knowledge; track record of cross-functional influence.
• Significant experience in immunology preferred; understanding of biology, translational medicine, pharmacology, and dose selection.
• Strong understanding of regulatory expectations and commercialization impact; broad knowledge across exploratory development functions.
• Ability to create global vision and strategic priorities; lead cross-functional teams to execute development plans with differentiation and data-driven acceleration.
• Proven ability to assess complex data, make decisions under uncertainty, and present programs to senior leaders.
• Experience leading high-performing matrix teams and mentoring others; ability to multi-task across assets and timelines.

Skills

• Strategic thinking, problem solving, and strong communication
• Cross-functional leadership and collaboration
• Data-driven decision making and analytical reasoning
• Stakeholder management and external partnership development
• Clinical trial design, regulatory strategy, and commercialization considerations

Education

• MD, PhD, DVM, PharmD, MBA or equivalent advanced degree